Psychopharmacology and Alternatives for Mental Health Disorders

The Great Lakes MHTTC offers this training for behavioral health professionals in HHS Region 5: IL, IN, MI, MN, OH, an WI.  This training is offered in response to a need identified by Region 5 stakeholders.

This is a two-part series:  July 13 and July 15, 2021.

 

July 13, 2021
Part 1: Psychopharmacology and Alternatives for Mental Health Disorders 

The release of interesting, approved psychiatric medications has slowed considerably in the last few years. Pharmaceutical companies continue to focus on trying to find the next Prozac, but progress is slow. In the two hours of Part 1, we will discuss the placebo effect and treatment adherence, client age and culture, and pharmacogenetic testing. We will then explore the latest research about antidepressants, including ketamine; and antipsychotics.

 

Learning Objectives

 At the end of this day, participants will:

  • Have reviewed the basic understanding of chemical treatments of depression and psychosis
  • Be introduced to data concerning compliance with treatment and pharmacogenetic testing
  • Learn about the possible new directions in treating depression and suicidality

 

July 15, 2021
Part 2:  

In Part 2 of this webinar on psychopharmacology we will look at drugs to treat bipolar disorder, substance misuse, ADHD, and some alternative medications in mental health, including street drugs. Throughout both part 1 and part 2, we will look at side effects and how people may misinterpret them as behavior problems

 

 

Learning Objectives

At the end of this day, participants will;

  • Become familiar with pharmacological treatments for bipolar disorder and substance use
  • Understand the fundamental differences of treatments for ADHD
  • Know how alternative medications and street drugs fit into psychiatric treatment research

 

Presenter: David Mays, PhD, University of Wisconsin Dept. of Psychiatry

David MaysDr. Mays is a Distinguished Life Fellow of the American Psychiatric Association, member the Wisconsin Psychiatric Association, and a member of the American Academy of Psychiatry and the Law. Over his career, Dr. Mays has practiced psychiatry in a variety of settings, including an HMO, an assertive community treatment program, private clinical and forensic practice, and as the clinical director of the forensic program at the Mendota Mental Health Institute.

Dr. Mays has received numerous awards for his teaching and clinical work, including the Distinguished Service Award from the Alliance on Mental Illness in Dane County, the Exemplary Psychiatrist Award from the National Alliance on Mental Illness, the Exceptional Performance Award from the Wisconsin Health and Family Services, the Outstanding Professional Award from the Wisconsin Association on Alcohol and Other Drug Abuse, and the Outstanding Mental Health Professional Award from the Wisconsin National Alliance on Mental Illness. He is a highly sought-after presenter on numerous topics in mental health, including psychiatric diagnosis and treatment, personality disorders, suicide and aggression risk management, mainstream and alternative treatments in psychiatry, and the biology of ethics.

 

 

Continuing Education 

Four CE credit hours will be available for those who attend the full webinar. WAFCA will provide 4 NBCC continuing education hours to those who attend the entire four-hour training event. Partial credit will be provided to those who choose to attend only part of the event.

Starts: Jul 13, 2021 10:00 am
Ends: Jul 15, 2021 12:00 pm
Timezone:
US/Central
Registration Deadline
July 11, 2021
Register
Event Type
Webinar/Virtual Training
Hosted by
Contact Us for More Info
Copyright © 2024 Mental Health Technology Transfer Center (MHTTC) Network
map-markercalendar-fullmagnifiercrossmenuchevron-down